EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction and validation of a SASP ‐related prognostic signature in patients with acute myeloid leukaemia

Ming-Feng Li iD, Dong-Hui Zhang, Li-Si Wang, Cai-Feng Yue, Li-Juan Pang, Yun-Miao Guo, Zhi-Gang Yang iD

Journal of Cellular and Molecular Medicine · 2024-08 · 28 (16)

DOI: 10.1111/jcmm.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 19.08.2024. Verfasst von Ming-Feng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang,…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukaemia (AML) is a common and highly aggressive haematological malignancy in adults. Senescence‐associated secretory phenotype (SASP) plays important roles in tumorigenesis and progression of tumour. However, the prognostic value of SASP in patients with AML has not been clarified. The present study aims to explore the prognostic value of SASP and develop a prognostic risk signature for AML. The RNA‐sequencing data was collected from the TCGA, GTEx and TARGET databases. Subsequently, differentially expressed gene analysis, univariate Cox regression and LASSO regression were applied to identified prognostic SASP‐related genes and construct a prognostic risk‐scoring model. The risk score of each patient were calculated and patients were divided into high‐ or low‐risk groups by the median risk score. This novel prognostic signature included 11 genes: G6PD , CDK4 , RPS6KA1 , UBC , H2BC12 , KIR2DL4 , HSF1 , IFIT3 , PIM1 , RUNX3 and TRIM21 . The patients with AML in the high‐risk group had shorter OS, demonstrating that the risk score acted as a prognostic predictor, which was validated in the TAGET‐AML dataset. Univariate and multivariate analysis revealed the risk score was an independent prognostic factor in patients with AML. Furthermore, the present study revealed that the risk score was associated with immune landscape, immune checkpoint gene expression and chemotherapeutic efficacy. In the present study, we constructed and validated a unique SASP‐related prognostic model to assess therapeutic effect and prognosis in patients with AML, which might contribute to understanding the role of SASP in AML and guiding the treatment for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteBiomarkers, TumorHumansPrognosisFemaleMaleGene Expression ProfilingMiddle AgedGene Expression Regulation, LeukemicTranscriptomeAdultRisk Factors

Stichwörter der Autor:innen

acute myeloid leukaemia (AML)immune infiltrationprognosisrisk signaturesenescence‐associated secretory phenotype (SASP)

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.
  • Department of Laboratory Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.
  • Department of Pathology, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.
  • Department of Hematology, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.

ORCID-Profile: Ming-Feng Li, Zhi-Gang Yang

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Li, M. F., Zhang, D. H., Wang, L. S., Yue, C. F., Pang, L. J., Guo, Y. M., & Yang, Z. G. (2024). Construction and validation of a SASP ‐related prognostic signature in patients with acute myeloid leukaemia. Journal of Cellular and Molecular Medicine, 28(16). https://doi.org/10.1111/jcmm.70017

Vancouver

Li MF, Zhang DH, Wang LS, Yue CF, Pang LJ, Guo YM, et al. Construction and validation of a SASP ‐related prognostic signature in patients with acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 2024;28(16). doi:10.1111/jcmm.70017

BibTeX
@article{Li2024,
  author = {Li, Ming-Feng and Zhang, Dong-Hui and Wang, Li-Si and Yue, Cai-Feng and Pang, Li-Juan and Guo, Yun-Miao and Yang, Zhi-Gang},
  title = {Construction and validation of a SASP ‐related prognostic signature in patients with acute myeloid leukaemia},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {16},
  doi = {10.1111/jcmm.70017}
}
Kostenlos starten →